Invention Grant
US08497372B2 Use of substituted quinazoline compounds in treating age-related macular degeneration
有权
使用取代喹唑啉化合物治疗年龄相关性黄斑变性
- Patent Title: Use of substituted quinazoline compounds in treating age-related macular degeneration
- Patent Title (中): 使用取代喹唑啉化合物治疗年龄相关性黄斑变性
-
Application No.: US13487434Application Date: 2012-06-04
-
Publication No.: US08497372B2Publication Date: 2013-07-30
- Inventor: Wei-Guo Su , Weihan Zhang , Xiaoqiang Yan , Yumin Cui , Yongxin Ren , Jifeng Duan
- Applicant: Wei-Guo Su , Weihan Zhang , Xiaoqiang Yan , Yumin Cui , Yongxin Ren , Jifeng Duan
- Applicant Address: BS Nassau
- Assignee: Hutchison Medipharma Enterprises Limited
- Current Assignee: Hutchison Medipharma Enterprises Limited
- Current Assignee Address: BS Nassau
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07D239/72
- IPC: C07D239/72
Abstract:
Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.
Public/Granted literature
- US20120238572A1 USE OF SUBSTITUTED QUINAZOLINE COMPOUNDS IN TREATING ANGIOGENESIS-RELATED DISEASES Public/Granted day:2012-09-20
Information query
